MSB 3.42% $1.21 mesoblast limited

Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-305

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,431 Posts.
    lightbulb Created with Sketch. 541
    You do know that SI himself holds close to 70 million shares and is by far the largest individual share holder in the company.
    Now common sense would tell us SI more than anyone else want 'shareholder' wealth to increase by kicking goals and increasing share price.

    FDA rejection is just a short term blip.

    Very positive announcement.
    Norvartis is one of the largest pharmaceutical company in the world and by they wouldn't be signing deals with MSB if they did not believe in the product.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.